Company Performance: Strong revenue growth, profitability, and positive earnings reports typically boost investor confidence and increase the stock price. Poor financial results can have the opposite effect.

Industry Trends: The overall health and growth prospects of the pharmaceutical industry in China, particularly for segments related to the company's products, influence the stock price.

Regulatory Changes: Changes in government regulations regarding drug approvals, pricing policies, healthcare reforms, and environmental regulations can significantly impact the company's future earnings and investor sentiment.

Market Sentiment: General market optimism or pessimism, as reflected in indices like the Shanghai Composite, can influence the buying and selling pressure on the stock.

Competition: The competitive landscape, including the emergence of new competitors or the introduction of competing products, can affect the company's market share and profitability.

Economic Conditions: Macroeconomic factors such as GDP growth, inflation, interest rates, and currency exchange rates can affect the overall investment climate and company's performance.

Global Events: Global health crises, international trade policies, and geopolitical events can have both direct and indirect impacts on the company and the stock price.

Investor Sentiment: News releases, analyst ratings, and overall investor perception of the company and its prospects influence trading activity and stock valuation.